SCHEMBL4873288

SCHEMBL4873288

CCCCCCCCOc1ccc(-c2ccc(-c3ccc(OCCCCO[Si](C)(C)[Si](C)(C)C)cc3)c(F)c2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.45
CYP1A2 P05177 4/20 0.45
CYP19A1 P11511 4/20 0.45
CYP2C9 P11712 4/20 0.45
CYP2C19 P33261 4/20 0.45
NR5A1 Q13285 1/20 0.44
RARB P10826 3/20 0.44
CYP3A4 P08684 4/20 0.43
PTPN11 Q06124 2/20 0.43
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
HTR1B P28222 1/20 0.42
HTR2B P41595 1/20 0.42
TSHR P16473 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4871491 0.94 CYP2D6 (0.40) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL4863888 0.94 CYP2D6 (0.40) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL4872106 0.93 MEN1 (0.48) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL4867562 0.93 RARB (0.41) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9494586 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9494660 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9494088 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9494594 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9493546 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9496980 0.87 NR5A1 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351452-B2 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2008-04-01 US disclosed
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core YBX1, AFF1, AFF2 CYP2D6 336/4885CYP1A2 108/4885CYP19A1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.